- IDEXX Laboratories (NASDAQ:IDXX) Q2 results: Revenues: $580.8M (+14.1%); CAG: $507.5M (+15.4%).
- Net Income: $108.7M (+27.3%); EPS: $1.23 (+29.5%); CF Ops: $153.7M (+8.6%).
- 2018 Guidance: Revenue: $2,205M - 2,230M from $2,205M - 2,245M; EPS: $4.10 - 4.20 from $4.06 - 4.20.
- The company achieves 3,241 premium instrument placements, representing 21% Y/Y growth.
- Shares are down a fraction premarket.
IDEXX Laboratories Q2 revenues up 14%; EPS up 30%; raises EPS guidance
Recommended For You
More Trending News
About IDXX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
IDXX | - | - |
IDEXX Laboratories, Inc. |